Skip to main
RMD

ResMed (RMD) Stock Forecast & Price Target

ResMed (RMD) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 30%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

ResMed is experiencing strong revenue growth through device and mask sales, and an expanding gross margin has propelled its FY26 revenue and earnings above expectations. Additionally, ResMed's strategic focus on digital health positions it to benefit from the growing demand for out-of-hospital care. However, potential competition in international markets and uncertainties around operating expenses may give some investors pause.

Bears say

ResMed is facing challenges in its growth potential due to a slowing market for respiratory care devices, which is reflected in its underperformance in key regions like Europe, Asia and other international markets. The company is also facing increased expenses, driven in part by acquisitions, which is weighing on its earnings. Management's lowered growth outlook for its Residential Care Software segment also raises concerns about the company's future growth potential.

ResMed (RMD) has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 30% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ResMed and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ResMed (RMD) Forecast

Analysts have given ResMed (RMD) a Buy based on their latest research and market trends.

According to 10 analysts, ResMed (RMD) has a Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $275.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $275.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ResMed (RMD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.